Economics of Innovation
Optimal innovation balances willingness and ability to pay with the benefits of future R&D. Our wide-ranging programme aims to promote innovation in health care, increase our understanding of its value, and encourage R&D. New models of innovation should streamline development, reduce costs, and speed patient benefit.
New Publication: Bibliometric Trends of Health Economic Evaluation in Sub-Saharan Africa
8 November 2016
A new study which explores the relationship between sub-Saharan African authors and their respective co-authors has been published in Globalization and Health. The study was a…
New Report Published: Improving Efficiency and Resource Allocation in Future Cancer Care
26 September 2016
The Office of Health Economics (OHE) and the Swedish Institute for Health Economics (IHE) publish a report evaluating the efficiency of resource allocation in cancer care…
OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes Advice on Medicinal Drug Development
23 August 2016
On Wednesday 5th October, OHE will host a lunchtime seminar on the topic of: Health Technology Assessment Scientific and Outcomes Advice on Medicinal Drug Development: Current…
OHE at AES 2016: Early Access Schemes, Equity Adjusted QALYs, Multi-indication Pricing and Formulary Development
2 August 2016
The Spanish Health Economics Association (AES) Conference was held at the University of Murcia, 15-18th June 2016. The topic of the meeting was “Reforms under the…
The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics
5 July 2016
“Complementary diagnostics” are defined as tests using biomarkers for risk assessment, diagnosis, prognosis, monitoring, and guiding therapeutic decisions. This White Paper presents a more comprehensive framework for considering their value contribution.
What Drives Variations in Relative Effectiveness Across Countries?
31 May 2016
This study provides an analytical framework, drawing on production function theory, to identify and quantify the determinants of relative effectiveness and sources of variation in the…
New publication: The current and future burden of late-onset dementia in the UK: estimates and interventions
10 May 2016
A new publication, based on research conducted by OHE, suggests that by 2025 the disability adjusted life year (DALY) burden of dementia will have increased by…
New Publication: Spillovers between Public and Private Sector Biomedical and Health Research
8 March 2016
OHE’s Yan Feng and Jorge Mestre-Ferrandiz have co-authored a new publication on quantifying the spillovers between public and private sector biomedical and health research and development…
Just Published: OHE Report on Trends in Scottish Medicines Committee Advice Decisions
25 February 2016
An analysis in the trends in Scottish Medicines Committee (SMC) advice decisions for medicines for the period October 2009 to September 2015 has just been published…